Geneva, Aug. 6 -- International Clinical Trials Registry received information related to the study (NCT07737158) titled 'Venlafaxine for Non-specific Low Back Pain' on July 27.
Study Type: Interventional
Study Design:
Allocation: Randomized. Intervention model: Parallel Assignment. Primary purpose: Treatment. Masking: Single (Outcomes Assessor).
Primary Sponsor: Beijing Tiantan Hospital
Condition:
Non-specific Low Back Pain
Pain Management
Intervention:
Drug: Control Group
Recruitment Status: Not recruiting
Phase: N/A
Date of First Enrollment: September 1, 2026
Target Sample Size: 228
Countries of Recruitment:
China
To know more, visit https://clinicaltrials.gov/study/NCT07737158
Disclaimer: Curated by HT Syndication....